These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 34822762)

  • 21. Screening for colorectal cancer in Italy: 2011-2012 survey.
    Zorzi M; Mangone L; Anghinoni E; Baracco S; Borciani E; Caldarella A; Falcini F; Fanetti AC; Ferretti S; Giorgi Rossi P; Michiara M; Randi G; Stracci F; Vicentini M; Zucchetto A; Zappa M;
    Epidemiol Prev; 2015; 39(3 Suppl 1):108-14. PubMed ID: 26405782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interval cancers after negative immunochemical test compared to screen and non-responders' detected cancers in Slovenian colorectal cancer screening programme.
    Mlakar DN; Bric TK; Škrjanec AL; Krajc M
    Radiol Oncol; 2018 Jul; 52(4):413-421. PubMed ID: 30511936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of screening and universal healthcare on long-term colorectal cancer mortality.
    Lee YC; Hsu CY; Chen SL; Yen AM; Chiu SY; Fann JC; Chuang SL; Hsu WF; Chiang TH; Chiu HM; Wu MS; Chen HH
    Int J Epidemiol; 2019 Apr; 48(2):538-548. PubMed ID: 30184208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.
    Larsen MB; Njor S; Ingeholm P; Andersen B
    Gastroenterology; 2018 Jul; 155(1):99-106. PubMed ID: 29626451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proportional incidence of interval colorectal cancer in a large population-based faecal immunochemical test screening programme.
    Mancini S; Bucchi L; Giuliani O; Ravaioli A; Vattiato R; Baldacchini F; Ferretti S; Sassoli de Bianchi P; Mezzetti F; Triossi O; Serafini M; Ricci E; Palazzi M; Imolesi C; Giovanardi M; Canuti D; Voci C; Altini M; Falcini F
    Dig Liver Dis; 2020 Apr; 52(4):452-456. PubMed ID: 32165075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of faecal occult blood test interval cancers in population-based colorectal cancer screening: a systematic review and meta-analysis.
    Wieten E; Schreuders EH; Grobbee EJ; Nieboer D; Bramer WM; Lansdorp-Vogelaar I; Bruno MJ; Kuipers EJ; Spaander MCW
    Gut; 2019 May; 68(5):873-881. PubMed ID: 29934436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
    Forsberg A; Westerberg M; Metcalfe C; Steele R; Blom J; Engstrand L; Fritzell K; Hellström M; Levin LÅ; Löwbeer C; Pischel A; Strömberg U; Törnberg S; Wengström Y; Ekbom A; Holmberg L; Hultcrantz R;
    Lancet Gastroenterol Hepatol; 2022 Jun; 7(6):513-521. PubMed ID: 35298893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No decrease in the rate of early or missed colorectal cancers after colonoscopy with polypectomy over a 10-year period: a population-based analysis.
    Pullens HJ; Leenders M; Schipper ME; van Oijen MG; Siersema PD
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):140-7. PubMed ID: 24815328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study.
    Cardoso R; Guo F; Heisser T; Hackl M; Ihle P; De Schutter H; Van Damme N; Valerianova Z; Atanasov T; Májek O; Mužík J; Nilbert MC; Tybjerg AJ; Innos K; Mägi M; Malila N; Bouvier AM; Bouvier V; Launoy G; Woronoff AS; Cariou M; Robaszkiewicz M; Delafosse P; Poncet F; Katalinic A; Walsh PM; Senore C; Rosso S; Vincerževskienė I; Lemmens VEPP; Elferink MAG; Johannesen TB; Kørner H; Pfeffer F; Bento MJ; Rodrigues J; Alves da Costa F; Miranda A; Zadnik V; Žagar T; Lopez de Munain Marques A; Marcos-Gragera R; Puigdemont M; Galceran J; Carulla M; Chirlaque MD; Ballesta M; Sundquist K; Sundquist J; Weber M; Jordan A; Herrmann C; Mousavi M; Ryzhov A; Hoffmeister M; Brenner H
    Lancet Oncol; 2021 Jul; 22(7):1002-1013. PubMed ID: 34048685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme.
    Larsen MB; Njor SH; Jensen TM; Ingeholm P; Andersen B
    Scand J Gastroenterol; 2019 Aug; 54(8):1008-1014. PubMed ID: 31397598
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
    de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Faecal immunochemical test-based colorectal cancer screening programme SVIT in Slovenia: pilot phase.
    Tepeš B; Stabuc B; Stefanovič M; Bračko M; Frkovič Grazio S; Novak Mlakar D; Maučec Zakotnik J
    Eur J Cancer Prev; 2014 Jul; 23(4):235-9. PubMed ID: 24030444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of Interval Colorectal Cancer After Negative Results From First-Round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age.
    Toes-Zoutendijk E; Kooyker AI; Dekker E; Spaander MCW; Opstal-van Winden AWJ; Ramakers C; Buskermolen M; van Vuuren AJ; Kuipers EJ; van Kemenade FJ; Velthuysen MF; Thomeer MGJ; van Veldhuizen H; van Ballegooijen M; Nagtegaal ID; de Koning HJ; van Leerdam ME; Lansdorp-Vogelaar I;
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1493-1500. PubMed ID: 31442598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of the Czech National Colorectal Cancer screening programme -  faecal occult blood tests].
    Seifert B; Májek O; Zavoral M; Král N; Suchánek S; Ngo O; Dušek L
    Klin Onkol; 2014; 27 Suppl 2():87-97. PubMed ID: 25494893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.
    Peng SM; Hsu WF; Wang YW; Lin LJ; Yen AM; Chen LS; Lee YC; Wu MS; Chen TH; Chiu HM
    Gut; 2021 Jul; 70(7):1318-1324. PubMed ID: 32989019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Concentrations of Hemoglobin Determined by Fecal Immunochemical Tests and Long-term Development of Advanced Colorectal Neoplasia.
    Grobbee EJ; Schreuders EH; Hansen BE; Bruno MJ; Lansdorp-Vogelaar I; Spaander MCW; Kuipers EJ
    Gastroenterology; 2017 Nov; 153(5):1251-1259.e2. PubMed ID: 28760383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-colonoscopy colorectal cancers in a national fecal immunochemical test-based colorectal cancer screening program.
    Wisse PHA; de Boer SY; Oudkerk Pool M; Terhaar Sive Droste JS; Verveer C; Meijer GA; Dekker E; Spaander MCW
    Endoscopy; 2024 May; 56(5):364-372. PubMed ID: 38101446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia-Brussels colorectal cancer screening programme.
    Guo F; De Brabander I; Francart J; Candeur M; Polus M; Van Eycken L; Brenner H
    Br J Cancer; 2020 Mar; 122(7):1109-1117. PubMed ID: 32066910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for colorectal cancer in Italy: 2011-2012 survey.
    Zorzi M; Mangone L; Sassatelli R; Baracco S; Budroni M; Castaing M; Cirilli C; Cusimano R; Fusco M; Giacomin A; Giorgi Rossi P; Naldoni C; Pannozzo F; Piffer S; Puppo A; Tisano F; Zappa M;
    Epidemiol Prev; 2015; 39(3 Suppl 1):115-25. PubMed ID: 26405783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
    Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.